Australian Doctor 3rd November 2023 3rd Nov 23 | Page 27

27

How to Treat .

EARN CPD OR PDP POINTS

27

Complete How to Treat quizzes via ausdoc . com . au / how-to-treat

How to Treat Quiz

RACGP : 0.5 hours EA 0.5 hours RP ACRRM : 0.5 hours EA 0.5 hours RP Earn CPD or PDP points .
Go to ausdoc . com . au
/ how-to-treat
NEED TO KNOW
Cutaneous melanoma is a common cancer in Australia and can affect younger adults .
Identify the patient ’ s individual risk factors and use a melanoma risk calculator to determine approximate risk .
The frequency of full skin examinations is determined by the individual risk :
— Perform this examination with appropriate exposure , lighting and magnification .
Any new or changing pigmented melanocytic lesions in an adult warrants biopsy .
Use a shave biopsy / saucerisation technique only for lesions that are clinically superficial with no nodular or elevated areas .
An excisional biopsy with 2mm clinical margin is the biopsy method of choice for suspected melanoma :
— Sentinel lymph node biopsy ( SLNB ) may not be possible with a larger initial margin .
Refer patients with melanomas with Breslow thickness greater than 0.8mm to a melanoma surgeon for possible SLNB , which is performed concurrently with the wide local excision .
Full body photography is an adjunct to full skin examinations in high-risk patients .
Offer psychological support to patients diagnosed with melanoma .

Melanoma

Dr Lisa Byrom ( left ) Consultant dermatologist , Mater Hospital Brisbane , Townsville University Hospital ; senior lecturer for the University of Queensland , Brisbane , Queensland .
Dr Hannah Gribbin ( right ) Dermatology registrar , Brisbane , Queensland .
First published online on 19 May 2023
BACKGROUND
MELANOMA is a malignancy of melanocytes
and is considered Australia ’ s ‘ national cancer ’; more than 17,000 Australians were expected to be diagnosed with invasive malignant melanoma by the end of 2022 . 1 GPs are at the forefront of the diagnosis of cutaneous melanoma .
The availability of adjuvant therapies for patients with metastatic melanoma places utmost importance on accurate diagnosis , staging and management of cutaneous melanomas .
This How to Treat covers the aetiology , classification and treatment of primary cutaneous melanoma , and aims to ensure GPs can confidently diagnose and initiate management for these tumours .
Epidemiology
Melanoma is predominantly a skin malignancy ( see figure 1 ), though can form primary tumours wherever melanocytes reside , including the eyes ( see figure 2 ), gastrointestinal tract , leptomeninges and oral / genital mucosal membranes . Queensland has the highest incidence of melanoma in the world , with an estimated 72 cases per 100,000 in 2021 . 1 Melanoma is the second most common cancer in men , and the third most common cancer
in women ( excluding non-melanoma skin cancers ). In Australia it is the most common cancer diagnosed in young adults , aged 15-24 . 1
The incidence of melanoma in situ in Australia continues to increase across all age groups ; however , after an intensive 30-year sun education campaign , the incidence of invasive melanoma in Australia is decreasing in those aged under 40 . 2 , 3
Several explanations have been offered for the rising incidence of melanoma in Australia , including increased screening with resulting detection of more indolent lesions , and inconsistency in histologic analysis of early evolving lesions . However , this does not explain the increase in melanoma mortality rates , particularly in older males .
Melanoma remains a significant health burden in Australia , with the age-standardised mortality rate estimated to be four deaths per 100,000 persons in 2021 . 1
Aetiology and risk factors
THE development of melanoma is
multifactorial and results from an interplay of genetic susceptibility and environmental exposure . Clinical and epidemiological experience
show that there are likely two pathways to the development of melanoma , described by the ‘ divergent pathway ’ model . 4 , 5 This model proposes that individuals with a lower propensity to developing naevi require a greater degree of sun exposure to promote the formation of melanoma . 4 , 5 Conversely , in patients with high naevus counts , less sun exposure is required to drive the development of melanoma . Patients with melanoma can thus be stratified into two groups ( see box 1 ).
The well-recognised risk factors for the development of melanoma appear in box 2 .
UV radiation
A causative role for UV radiation ( UVR )
in development of melanoma is best demonstrated by the geographic incidence of melanoma , adjusted for skin type , and being highest in regions closest to the equator . In addition , the incidence of melanoma decreases proportionally with increasing distance from the equator and , therefore , lower levels of UVR exposure . 7
Intense , intermittent UVR exposure appears to be the most significant in terms of melanoma risk . This hypothesis is supported by a systematic review demonstrating
Box 1 . Stratification of patients with melanoma
• Low naevus count / high sunlight pathway .
• High naevus count / low sunlight pathway .
Box 2 . Well-recognised risk factors for melanoma
that • UVR sunburn exposure in childhood ( including or ado- blistering childhood sunburns ).
• Individual phenotypic traits ( lighter skin complexion , red hair , blue eyes ).
• High number of naevi .
• Family history of melanoma .
• Personal history of melanoma .
• Older age .
• Immunosuppression . Source : Curiel-Lewandrowski CA , et al 2022 6
lescence was strongly associated with increased risk of melanoma . 8 In addition , melanoma is common on body sites that undergo intense , intermittent sun exposure ( such as the back in men and the backs of the legs in women ). 9 The use of